Skip to main content
Fig. 4 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 4

From: Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation

Fig. 4

A 50-year-old female patient with NHL, treated with anti-cd20 antibody rituximab 5 months prior to vaccination. She was evaluated for left supraclavicular pain. Clinical data revealed that she had received the 2nd dose of Pfizer-BioNTech COVID-19 vaccine in her left arm 8 days prior to the PET/CT study. A Axial CECT image revealed enlarged left supraclavicular LN 2.6 cm. B Axial PET/CT image revealed enlarged FDG-avid left supraclavicular LN of 2 SUVmax

Back to article page